Spotlight on Pimavanserin Tartrate and Its Therapeutic Potential in the Treatment of Major Depressive Disorder: The Evidence to Date

Improvement of sexual functioning during treatment of MDD with adjunctive pimavanserin: A secondary analysis

(2020) Marlene P. Freeman et al.   DEPRESSION AND ANXIETY

Association between irritability and suicidal ideation in three clinical trials of adults with major depressive disorder

(2020) Manish K. Jha et al.   NEUROPSYCHOPHARMACOLOGY

Pharmacological Treatments for Patients with Treatment-Resistant Depression

(2020) Valerie L. Ruberto et al.   Pharmaceuticals

Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study

(2020) George I. Papakostas et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Improvements in irritability with sertraline versus placebo: Findings from the EMBARC study

(2020) Manish K. Jha et al.   JOURNAL OF AFFECTIVE DISORDERS

Effect of adjunctive pimavanserin on suicidal ideation in patients with major depression: Analysis of the CLARITY study

(2020) Richard C. Shelton et al.   JOURNAL OF AFFECTIVE DISORDERS

Depression in the Primary Care Setting

(2019) Lawrence T. Park et al.   NEW ENGLAND JOURNAL OF MEDICINE

Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity

(2019) Manish K. Jha et al.   AMERICAN JOURNAL OF PSYCHIATRY

Noninvasive Brain Stimulation: Challenges and Opportunities for a New Clinical Specialty

(2018) Aaron D. Boes et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States

(2018) Deborah S. Hasin et al.   JAMA Psychiatry

A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial

(2018) Madhukar H. Trivedi et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale

(2017) Manish K Jha et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2017) Theo Vos et al.   LANCET

Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial

(2016) Manish K. Jha et al.   AMERICAN JOURNAL OF PSYCHIATRY

Early normalization of Quality of Life predicts later remission in depression: Findings from the CO-MED trial

(2016) Manish K. Jha et al.   JOURNAL OF AFFECTIVE DISORDERS

The Role of Insomnia in Depression and Anxiety

(2016) Andrew J. Cutler   JOURNAL OF CLINICAL PSYCHIATRY

Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients

(2016) Manish K. Jha et al.   PLoS One

Placebo non-response measure in sequential parallel comparison design studies

(2015) Denis Rybin et al.   STATISTICS IN MEDICINE

Sexual dysfunction associated with major depressive disorder and antidepressant treatment

(2014) Anita H Clayton et al.   Expert Opinion On Drug Safety

On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson’s Psychosis

(2014) Uli Hacksell et al.   NEUROCHEMICAL RESEARCH

Defining anxious depression: a review of the literature

(2013) Dawn F. Ionescu et al.   CNS SPECTRUMS

Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype–targeted drugs

(2013) Herbert Y. Meltzer et al.   JOURNAL OF CLINICAL INVESTIGATION

Sexual Satisfaction and Quality of Life in Major Depressive Disorder Before and After Treatment With Citalopram in the STAR*D Study

(2013) Waguih William IsHak et al.   JOURNAL OF CLINICAL PSYCHIATRY

Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial

(2013) Jeffrey Cummings et al.   LANCET

QT interval and antidepressant use: a cross sectional study of electronic health records

(2013) V. M. Castro et al.   BMJ-British Medical Journal

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

(2011) Kelly Posner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Genetic and Clinical Predictors of Sexual Dysfunction in Citalopram-Treated Depressed Patients

(2009) Roy H Perlis et al.   NEUROPSYCHOPHARMACOLOGY

Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis

(2009) Herbert Y Meltzer et al.   NEUROPSYCHOPHARMACOLOGY

Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D Report

(2008) Maurizio Fava et al.   AMERICAN JOURNAL OF PSYCHIATRY